Pharmaceutical composition and its uses

A technology of composition and medicine, which is applied in the field of medicine, can solve the problems of not being fundamentally cured, unsatisfactory curative effect, long treatment cycle, etc., and achieve the effect of inhibiting platelet aggregation, good effect and quick effect

Inactive Publication Date: 2011-01-26
孙付江
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment of these methods cannot be cured fundamentally, and the treatment time is long and the price is expensive
As for the treatment of cardiovascular and cerebrovascular diseases induced by "three highs", there are currently many and complicated drugs, and the price is relatively expensive, but the curative effect is not ideal. Taking nitrates and other drugs as an example, the treatment cycle is long and the price is expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] The components are prepared according to the following parts by weight: toad: 0.1 part, leech: 0.01 part, silkworm: 0.01 part, musk: 0.0001 part, donkey-hide gelatin: 0.05 part, tortoise shell: 0.04 part, turtle shell: 0.04 part, half branch lotus: 0.05 parts, stone piercing: 0.05 parts, Zijinniu: 0.05 parts, American ginseng: 0.04 parts.

[0015] The 11 components are pulverized and mixed uniformly, and filled into capsules to prepare the pharmaceutical composition capsules of the present invention. Wherein the parts by weight of the above-mentioned 11 components are parts by weight contained in one capsule.

[0016] Specific implementation cases:

[0017] 1. Zhang, male, in his fifties, employee of a unit in Nanjing, has a history of hepatitis B for 5 years and liver cirrhosis for 3 years. He has not been cured after multiple treatments by experts. According to someone's introduction, when he came for treatment, his complexion was dark, his spirit was low, and he su...

Embodiment 2

[0022] The components are prepared according to the following parts by weight: toad: 0.06 part, leech: 0.016 part, silkworm: 0.016 part, musk: 0.00012 part, donkey-hide gelatin: 0.06 part, tortoise shell: 0.07 part, turtle shell: 0.07 part, half branch lotus: 0.09 parts, stone piercing: 0.08 parts, Zijinniu: 0.07 parts, American ginseng: 0.06 parts.

[0023] The pharmaceutical composition tablet of the present invention is prepared after the 11 components are subjected to a tableting process. Wherein the parts by weight of the above-mentioned 11 components are the parts by weight contained in one tablet.

[0024] Specific implementation cases:

[0025] 1. Feng, male, in his 70s, a retiree from a certain unit in Wuxi, has suffered from cerebrovascular disease for more than 5 years, and has not been cured after multiple treatments by experts. According to someone's introduction, the dose of the pharmaceutical composition tablet made by the above formula is one tablet each time...

Embodiment 3

[0030] Prepare components according to the following parts by weight: toad: 0.16 parts, leech: 0.004 parts, silkworm: 0.004 parts, musk: 0.00008 parts, donkey-hide gelatin: 0.03 parts, tortoise shell: 0.01 parts, turtle shell: 0.02 parts, half branch lotus: 0.01 parts, stone piercing: 0.02 parts, Zijinniu: 0.03 parts, American ginseng: 0.01 parts.

[0031] The pharmaceutical composition oral liquid of the present invention is prepared after the 11 components are prepared through the oral liquid preparation process. Wherein the parts by weight of the above-mentioned 11 components are parts by weight contained in a bottle of oral liquid.

[0032] Specific implementation cases:

[0033] 1. Mr. Zhou, male, in his fifties, general manager of a company in Nanjing, has suffered from hypertension and hyperlipidemia for more than 7 years. He has not been cured after multiple treatments by experts. Introduced by a person, I came here for treatment. The dosage of the oral liquid of the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition and belongs to the technical field of medicine. The pharmaceutical composition comprises the following compositions by weight portion: 0.06 to 0.16 portion of toad, 0.004 to 0.016 portion of leech, 0.004 to 0.016 portion of bombyx batryticatus, 0.00008 to 0.00012 portion of muskiness, 0.03 to 0.06 portion of ass-hide glue, 0.01 to 0.07 portion of plastrum testudinis, 0.02 to 0.07 portion of carapax amydae, 0.01 to 0.09 portion of portulaca grandiflora, 0.02 to 0.08 portion of longcoronate sage root, 0.03 to 0.07 portion of ardisia japonica and 0.01 to 0.06 portion of gen-seng. The pharmaceutical composition mainly treats hepatitis, liver ascites, hepatocirrhosis and liver positive and the like, also has the functions of activating blood, removing stasis, dredging vessels, promoting blood circulation, inhibiting platelet aggregation and strengthening cerebral blood flow, has special effects on cerebral blood vessel, apoplectic hemiplegia, coronary heart disease, angina pectoris, hypertension, hyperlipemia and the like and also has the efficacies of detumescence and detoxifcation.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition. Background technique [0002] Hepatitis, hepatic ascites and cirrhosis are common liver diseases that seriously endanger human health. At present, five types of hepatitis are known: A, B, C, D and E. Among them, hepatitis B is the most harmful to human beings, the most popular, and the highest incidence rate. However, although some progress has been made in the diagnosis and treatment of hepatitis B at home and abroad in recent years, some new drugs have also appeared, such as interferon, which is highly praised by foreign countries. In domestic trials, the effect is not good, and because of its high price , is not widely used. Some other medicines for treating liver diseases in China often fail to achieve the purpose of effectively treating hepatitis B because of their disadvantages such as poor curative effect, high price, rebound after drug wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/00A61K36/53A61K36/73A61P1/16A61P7/10A61P9/10A61P9/12A61P39/02A61K35/36
Inventor 孙付江
Owner 孙付江
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap